InsiderTrades

Form 4 for ACET Adicet Bio, Inc.

Accepted 2022-02-16 00:00:00 ET · period of report 2022-02-14 · accession 0001209191-22-010479 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2022-02-16 2022-02-14 ACET Harvey Brian Nicholas CFO A - Grant $0.00 +16.0K 59.3K +37% $0
2022-02-16 2022-02-14 ACET Harvey Brian Nicholas CFO F - Tax $14.27 -4,696 54.6K -8% -$67.0K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-14 A A 16,000 $0.00 59,304 D — — (F1) The Reporting Person was issued 80,000 Restricted Stock Units ("RSUs") on October 1, 2021, as previously reported on a Form 4 filed by the Reporting Person on October 5, 2021. Each RSU represents a contingent right to receive one share of common stock. A total of 32,000 of the RSUs shall vest in two (2) annual installments of 20% of the shares vesting, with the first tranche vesting on October 1, 2022 and the second tranche vesting on October 1, 2023. A total of 48,000 of the RSUs shall vest upon achievements of specific milestones outlined in the Reporting Persons Restricted Stock Unit Agreement. On February 14, 2022, upon the occurrence of the second performance milestone, 16,000 of the RSUs vested. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
2 Common Common Stock 2022-02-14 F D 4,696 $14.27 54,608 D — —